These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3881779)

  • 1. The interaction of drugs and endogeneous substances with HLA class-I antigens.
    Claas FH; van Rood JJ
    Prog Allergy; 1985; 36():135-50. PubMed ID: 3881779
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-A, B matching of pretransplant blood transfusion is associated with poor graft survival.
    Albert ED; Scholz S; Meixner U; Land W
    Transplant Proc; 1981 Mar; 13(1 Pt 1):175-7. PubMed ID: 7022817
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of donor-recipient HLA disparity in the development of humoral immune reactions in corneal transplantation.
    Wagner E; Pagé B; Roy R; Langlois A; Boisjoly HM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):226-7. PubMed ID: 8438280
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pretransplant activity of cytotoxic T-lymphocytes in non-related bone marrow donor/recipient combinations with a perfect HLA match].
    Rufer N; Breur B; Tiercy JM; Speiser D; Chapuis B; Gratwohl A; Jeannet M; Roosnek E
    Schweiz Med Wochenschr; 1993 Nov; 123(47):2257-8. PubMed ID: 8272799
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA-A,B or -DR alloantigens.
    Engelhard VH; Benjamin C
    J Immunol; 1982 Dec; 129(6):2621-9. PubMed ID: 6982933
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue typing for hematopoietic cell transplantation: HLA-DQB1 typing should be included.
    Horn PA; Elsner HA; Blasczyk R
    Pediatr Transplant; 2006 Sep; 10(6):753-4. PubMed ID: 16911505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Applications of the HLA system in human clinical medicine].
    Dupont E
    Rev Med Brux; 1988 May; 9(4):238-44. PubMed ID: 3406614
    [No Abstract]   [Full Text] [Related]  

  • 8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "towards tailor-made HLA mismatching".
    Claas FH; Roelen DL; Mulder A; Doxiadis II; Oudshoorn M; Heemskerk M
    Hum Immunol; 2006 Jun; 67(6):424-9. PubMed ID: 16728264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-HLA immunological factors in eighteen HLA-identical renal allografts.
    Dossetor JB; Kovithavongs T
    Proc Eur Dial Transplant Assoc; 1983; 19():438-44. PubMed ID: 6224209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood component transfusion & HLA (author's transl)].
    Tsuji K
    Rinsho Ketsueki; 1979 Sep; 20(9):1219-25. PubMed ID: 513310
    [No Abstract]   [Full Text] [Related]  

  • 12. Class-I-restricted human cytotoxic T lymphocytes directed against minor transplantation antigens and their possible role in organ transplantation.
    Goulmy E
    Prog Allergy; 1985; 36():44-72. PubMed ID: 3881782
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of HLA antigen disparity on CML reactivity.
    Dohi K; Ono E; Fukuda Y; Asahara T; Yahata H; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):503-6. PubMed ID: 6334675
    [No Abstract]   [Full Text] [Related]  

  • 14. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The HLA gene complex--methods for detection and clinical importance].
    Mayr WR
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):184. PubMed ID: 7919905
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
    de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: requirement of class I signal sequence-derived peptides for HLA-E recognition by a mouse cytotoxic T cell clone.
    Martinozzi S; Pacasova R; Boulouis HJ; Ulbrecht M; Weiss EH; Sigaux F; Pla M
    J Immunol; 1999 May; 162(10):5662-5. PubMed ID: 10229795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primed lymphocyte typing in man.
    Morling N
    Dan Med Bull; 1983 May; 30(3):158-76. PubMed ID: 6190618
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.